<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887053</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A01209-46</org_study_id>
    <nct_id>NCT02887053</nct_id>
  </id_info>
  <brief_title>Methodological Developments for Magnetic Resonance Imaging (MRI)</brief_title>
  <acronym>METHODO</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to optimize clinical MR protocols and to validate MR acquisition
      parameters.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality based on standard imaging quality criteria</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Image quality criteria will be :
Signal to Noise Ratio and Contrast to Noise Ratio measured in arbitrary units.
absence of blurring and artefacts will be assessed by at least one radiologist according to an ordinal scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>T1/T2 Quantitative sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For quantitative studies such as T1/T2 studies a T1/T2 quantification will be calculated. These parameters will be reported in ms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain Functional MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For functional MRI studies, brain activity will be described in terms of brain localisation based on blood oxygen level-dependent signal variation and its intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function MRI sub studies: volume</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. Parameters such as left ventricle (LV) and right ventricle (RV) end-diastolic volumes end-systolic volumes will be measured and reported in mL/m².</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac mass MRI sub studies: mass</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. LV and RV mass index will be measured and reported in g/m2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function MRI sub studies: ejection fraction</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. Ejection fraction for both ventricles will be calculated and reported in %.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion weighted MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For diffusion studies, the apparent diffusion coefficient (ADC) whic is a measure of the magnitude of diffusion (of water molecules) within tissue will be estimated (mm2/s).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion tensor MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>The fractional anisotropy (FA) which is a scalar value between zero and one, which describes the degree of anisotropy of a diffusion process, could also be estimated.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1650</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>All subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will have an MRI examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>All subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  to be over 18 year-old,

          -  to be able to give an informed consent,

          -  to have underwent a pre-inclusion medical examination,

          -  to present no contraindication to MR examination,

          -  to be enrolled in a social security plan.

        Exclusion Criteria:

          -  subject refusal,

          -  subject under a measure of legal protection,

          -  any contraindication to MR examination (active medical device, ferromagnetic foreign
             body, pregnancy, morbid obesity, claustrophobia, … ).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie Laurent, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Nancy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques Felblinger, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valérie Laurent, MD,PhD</last_name>
    <email>v.laurent@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Hossu, PhD</last_name>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>5400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Laurent, Md, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>September 14, 2016</last_update_submitted>
  <last_update_submitted_qc>September 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>Healthy subjects</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

